Takeda deepens AI drug discovery push with $1.7 billion Iambic deal
By Kamal Choudhury Feb 9 (Reuters) – Privately held Iambic said on Monday it has entered a multi-year…
Marty Makary addresses staff concerns over drug voucher program
WASHINGTON — At an employee town hall on Tuesday, Food and Drug Administration leaders tried to quell staff…
UnitedHealth shrinks, Medicare Advantage crackdown: Health Care Inc.
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
Roche moves obesity drug to pivotal trials after mid-stage success
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
Schrodinger to offer Eli Lilly’s AI drug discovery platform on its software
By Sneha S K Jan 9 (Reuters) – Schrodinger said on Friday it is collaborating with Eli Lilly…
Analysis-Alzheimer’s drug hunt learns from cancer fight’s multi-target playbook
By Deena Beasley Dec 12 (Reuters) – Alzheimer’s trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their…
FDA reviewers didn’t get to vote on first priority voucher drug
WASHINGTON — The Food and Drug Administration has promised companies that earn a Commissioner’s National Priority Voucher a one-…
Countries used to test drugs often don’t see the approved medicines, study finds
Numerous medicines are not accessible in many of the countries where they were tested before approval by the…
AbbVie parts ways with Calico
Unexpected uncoupling raises questions about the pace – and patience – of longevity drug discovery amid shifting pharma…
3 Fantastic Growth Opportunities for Eli Lilly That Go Beyond GLP-1 Drugs
Eli Lilly has been investing in radiopharmaceuticals, which can help revolutionize cancer care in the future. Its early…
New FDA priority review vouchers go to Lilly, Novo, Vertex
WASHINGTON — The Food and Drug Administration on Thursday announced the second batch of companies being granted a “Commissioner’s…
New method could improve manufacturing of gene-therapy drugs | MIT News
Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their…